Doug Biehn

Doug Biehn is the Chief Commercial Officer at Cala Health. Prior to joining Cala Health, Doug served as an Executive Vice President and Board Advisor at Enso. Doug has also served as the Chief Operating Officer at AliveCor Inc. and as the Executive Vice President of Marketing at iRhythm Technologies, Inc.

Doug has a track record of success in transforming businesses and driving growth. At Enso, they helped develop the commercial go to market strategy that led to the company's acquisition by Hing Health in 2021. At AliveCor, Doug delivered 8x revenue growth and increased margin by over 2x. Doug also successfully completed 2 rounds of venture funding that resulted in a 7x increase in valuation. And at iRhythm, they were responsible for the company's growth strategy and global marketing functions.

Doug's accomplishments have been recognized by their peers in the industry. Doug was named one of the "Most Innovative Healthcare Companies in the World" by Fast Company in recognition of their work at AliveCor.

Doug Biehn holds an MBA from the University of San Francisco School of Management and a Bachelors of Science from San Francisco State University, Lam Family College of Business. Doug is currently a financial literacy strategist at the University of California, Berkeley, Haas School of Business.

Doug Biehn works with Steve Higa - VP of Manufacturing & Quality, Tim Gallagher - Chief Financial Officer, and Bernard E. Shay - General Counsel. Doug Biehn reports to Renee Ryan, CEO. and Jeron Evans - VP, Sales reports to Doug Biehn.